Skip to main content

i3 Health’s Survey of Urologists Reveals Key Insights Into Learning Preferences

A survey conducted by i3 Health at the Society of Government Service Urologists (SGSU) Kimbrough Urological Seminar, held from January 18 to 22, 2023, in Tucson, Arizona, has provided valuable insights into urologists' preferred formats and desired topics of continuing medical education (CME) activities, as well as the most important factors they consider when choosing such activities. Additionally, survey participants were asked an additional set of questions regarding their confidence and comf...

Continue reading

Incorporating Patient-Reported Outcomes Into Prostate Cancer Treatment With Lisa Gudenkauf, PhD

At the recent American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium, Dr. Lisa Gudenkauf, an Applied Research Scientist at Moffitt Cancer Center, presented her team's research regarding the Functional Assessment of Cancer Therapy—Radionuclide Therapy (FACT-RNT), a novel patient-reported outcomes (PRO) measure for patients with prostate cancer. In this follow-up interview, Dr. Gudenkauf shares more about how the measure was developed, its importance for capturing the patient experience, and its future implementation into both clinical practice and trials.  

Continue reading

Reducing Risk of Prostate Cancer Progression Through Plant-Based Diets With Vivian Liu

At the recent American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium, Vivian Liu, Lead Clinical Research Coordinator at the University of California, San Francisco (UCSF) Osher Center for Integrative Health, presented her study investigating the association between plant-based diets and risk of disease progression in men with prostate cancer. In this follow-up interview, Ms. Liu shares additional insights into the positive health benefits of a plant-based diet for prostate cancer patients and survivors.  

Continue reading

Developing Fatigue Management Guidance for Prostate Cancer Patients With Stephen Freedland, MD

At the recent American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium, Dr. Stephen Freedland, Professor of Urology at Cedars-Sinai Medical Center, presented his research regarding patient perspectives on fatigue management in prostate cancer. In this follow-up interview, he elaborates on the current lack of information geared toward patients experiencing fatigue while receiving novel hormonal agents and his goal of creating guidance to fill this gap.  

Continue reading

How to Counsel Genitourinary Cancer Patients About COVID-19 Vaccine Safety With Hyma Polimera, MD

At the recent American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium, Dr. Hyma Polimera, a Hematology/Oncology Fellow at Penn State Cancer Institute, presented her research regarding COVID-19 vaccine behaviors and outcomes among patients with genitourinary cancers. In this follow-up interview, she explains the efficacy of COVID-19 vaccination among this population and shares advice for oncologists on how to counsel their patients with genitourinary cancers regarding vaccine...

Continue reading

Oncology Data Advisor™ Announces New Data Hubs!

To continue our mission to deliver up-to-date, clinically relevant content from the health care community, we have created NEW Oncology Data Advisor Data Hubs. Each Data Hub is categorized by tumor type to make it easy for all members of the oncology team to find the most up-to-date information from across the health care landscape. View the Data Hubs below now!